News
3B Blackbio DX consolidated net profit rises 13.81% in the March 2026 quarter
29-May-2026 | 17:25
Sales rise 57.47% to Rs 35.43 crore
Net profit of 3B Blackbio DX rose 13.81% to Rs 9.56 crore in the quarter ended March 2026 as against Rs 8.40 crore during the previous quarter ended March 2025. Sales rose 57.47% to Rs 35.43 crore in the quarter ended March 2026 as against Rs 22.50 crore during the previous quarter ended March 2025.
For the full year,net profit rose 22.96% to Rs 58.59 crore in the year ended March 2026 as against Rs 47.65 crore during the previous year ended March 2025. Sales rose 47.11% to Rs 141.92 crore in the year ended March 2026 as against Rs 96.47 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 35.43 | 22.50 | 57 | 141.92 | 96.47 | 47 |
| OPM % | 23.96 | 35.20 | - | 40.00 | 51.94 | - |
| PBDT | 18.54 | 12.82 | 45 | 82.10 | 65.08 | 26 |
| PBT | 14.65 | 12.54 | 17 | 76.97 | 64.00 | 20 |
| NP | 9.56 | 8.40 | 14 | 58.59 | 47.65 | 23 |
Powered by Capital Market - Live News